作者: Steven H. Woolf
DOI: 10.1007/978-1-4612-3280-3_40
关键词:
摘要: Recent clinical trials such as the Lipid Research Clinics (LRC) Coronary Primary Prevention Trial1,2 and, more recently, Helsinki Heart Study3 have demonstrated that lowering serum cholesterol can reduce incidence of coronary heart disease (CHD) in middle-aged men with hyperlipidemia. Beginning 1984, these findings stimulated encouragement public to consume less dietary fat and promotion detection treatment persons Physicians, particular, received specific guidelines from National Institutes Health Consensus Conference on Lowering Blood Cholesterol4 Cholesterol Education Program5 measure prescribe appropriate and/or pharmacologic interventions lipids a “desirable” level.